In this section we provide relevant literature on different cardiovascular topics. Click on the links to access to each paper. Angiogenesis >
Atherosclerosis Atrial fibrillation Burden of cardiovascular diseases Biomarkers Cardiomyocytes Baum J, Duffy HS. Fibroblasts and myofibroblasts: what are we talking about? J Cardiovasc Pharmacol. 2011 Apr;57(4):376-9. Vasquez C, Benamer N, Morley GE. The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts. J Cardiovasc Pharmacol. 2011 Apr;57(4):380-8. Yue L, Xie J, Nattel S. Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res. 2011 Mar 1;89(4):744-53. Krenning G, Zeisberg EM, Kalluri R. Leask A. Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res. 2010 Jun 11;106(11):1675-80. Kakkar R, Lee RT. Souders CA, Bowers SL, Baudino TA. Manso AM, Kang SM, Ross RS. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol. 2010 Jan;7(1):30-7. Snider P, Standley KN, Wang J, Azhar M, Doetschman T, Conway SJ. Rohr S. Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm. 2009 Jun;6(6):848-56. Porter KE, Turner NA. Camelliti P, Green CR, Kohl P. Structural and functional coupling of cardiac myocytes and fibroblasts. Adv Cardiol. 2006;42:132-49. Baudino TA, Carver W, Giles W, Borg TK. Brown RD, Ambler SK, Mitchell MD, Long CS. The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol. 2005;45:657-87. Manabe I, Shindo T, Nagai R. Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res. 2002 Dec 13;91(12):1103-13. Cardiac development Cardiac fibers
Dilated cardiomyopathy
Hypertension and heart disease Ischemic heart disease
Stem cells and heart Stroke |